The pharmaceutical industry is coming out with new product and therapeutic innovations at a rapid pace. For example, cell and gene therapy is one of the many areas exploding with possibilities for novel treatments of formerly life-threatening conditions. The pressure to bring these new treatments to market quickly, efficiently, and with dependable quality has increased accordingly. Alongside this explosion of innovative solutions is an expectation to continuously improve your products and processes.
The Product Development and Product Systems track at the 2018 ISPE Annual Meeting & Expo in Philadelphia, PA, USA will address this paradigm shift with sessions and workshops presented by experienced practitioners who will share their experiences and solutions to today’s challenges.
The Product Development and Product Systems track will explore how new technologies and thinking will change the product development and manufacturing processes, and their impact on the future state of the industry, through the integration of:
The following topics will be covered:
The Product Development and Product Systems track team looks forward to meeting with you in Philadelphia this November to discuss challenges and share knowledge and solutions.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...